| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.53 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.09 |